Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV2024-04-30 | Chg.-0.7600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 237.7400EUR | -0.32% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | - | - | - | -2.07 | 6.28 | 2.52 | 0.74 | -2.26 | 2.63 | 9.16 | 3.09 | - |
| 2020 | -0.26 | -4.57 | -3.04 | 12.24 | 6.81 | 0.37 | -0.88 | 0.93 | 5.50 | -1.62 | 2.97 | 1.47 | +20.47% |
| 2021 | 1.20 | -4.18 | 3.11 | -0.16 | -1.08 | 6.25 | -1.03 | 5.97 | -2.06 | 3.45 | -3.82 | 2.85 | +10.28% |
| 2022 | -9.27 | -2.01 | 5.56 | -0.78 | -2.91 | 2.43 | 6.93 | -1.86 | -2.27 | 6.01 | 1.74 | -6.92 | -4.65% |
| 2023 | 0.31 | -1.64 | -1.12 | 1.12 | 0.82 | -2.28 | -0.25 | -0.55 | -2.93 | -6.28 | 5.72 | 4.36 | -3.22% |
| 2024 | 3.00 | 4.46 | 1.62 | -2.49 | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.94% | 11.05% | 11.13% | 14.07% | 17.21% |
| Sharpe ratio | 1.63 | 3.38 | 0.04 | -0.07 | 0.34 |
| Best month | +4.46% | +5.72% | +5.72% | +6.93% | +12.24% |
| Worst month | -2.49% | -6.28% | -6.28% | -9.27% | -9.27% |
| Maximum loss | -5.24% | -5.24% | -14.64% | -19.83% | -25.60% |
| Outperformance | - | - | - | - | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,286.1599 | +2.84% | +0.26% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,442.7600 | +2.97% | +0.63% | |
| Candriam Equities L Oncology Imp... | reinvestment | 198.3500 | -0.60% | -10.04% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,170.2200 | +2.01% | +9.81% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,534.5200 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 237.7400 | +4.28% | +8.68% | |
| Candriam Equities L Oncology Imp... | paying dividend | 225.1200 | +1.55% | -3.45% | |
| Candriam Equities L Oncology Imp... | paying dividend | 182.2200 | +2.42% | -0.99% | |
| Candriam Equities L Oncology Imp... | paying dividend | 19,992.0000 | -0.45% | -2.73% | |
| Candriam Equities L Oncology Imp... | reinvestment | 153.5400 | +1.89% | +9.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,015.7000 | +0.34% | -7.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 251.7900 | +5.16% | +11.46% | |
| Candriam Equities L Oncology Imp... | reinvestment | 197.9000 | -0.99% | -11.09% | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.2300 | +2.41% | -1.00% | |
| Candriam Equities L Oncology Imp... | reinvestment | 185.1400 | +0.23% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,789.7600 | +2.33% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,746.7000 | +2.51% | -0.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 152.8800 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 261.5600 | +1.56% | -3.47% |
Performance
| YTD | +6.61% | ||
|---|---|---|---|
| 6 Months | +18.74% | ||
| 1 Year | +4.28% | ||
| 3 Years | +8.68% | ||
| 5 Years | +58.57% | ||
| Since start | +58.49% | ||
| Year | |||
| 2023 | -3.22% | ||
| 2022 | -4.65% | ||
| 2021 | +10.28% | ||
| 2020 | +20.47% | ||
